Correlation Between Enanta Pharmaceuticals and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Candel Therapeutics, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Candel Therapeutics.
Diversification Opportunities for Enanta Pharmaceuticals and Candel Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enanta and Candel is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Candel Therapeutics
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 4.54 times less risky than Candel Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 173.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 1,178 from holding Candel Therapeutics or generate 680.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enanta Pharmaceuticals vs. Candel Therapeutics
Performance |
Timeline |
Enanta Pharmaceuticals |
Candel Therapeutics |
Enanta Pharmaceuticals and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enanta Pharmaceuticals and Candel Therapeutics
The main advantage of trading using opposite Enanta Pharmaceuticals and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Enanta Pharmaceuticals vs. Equillium | Enanta Pharmaceuticals vs. DiaMedica Therapeutics | Enanta Pharmaceuticals vs. Valneva SE ADR | Enanta Pharmaceuticals vs. Vivani Medical |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |